

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | porphyrin-containing compound metabolic process (GO:0006778) | 9.31801402 |
| 2 | heme metabolic process (GO:0042168) | 9.02156726 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 7.61655879 |
| 4 | erythrocyte maturation (GO:0043249) | 7.56145163 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 7.43826902 |
| 6 | hemoglobin metabolic process (GO:0020027) | 7.10596295 |
| 7 | response to methylmercury (GO:0051597) | 6.77064445 |
| 8 | protein neddylation (GO:0045116) | 6.30894021 |
| 9 | regulation of platelet aggregation (GO:0090330) | 6.12034056 |
| 10 | tetrapyrrole metabolic process (GO:0033013) | 6.03056588 |
| 11 | erythrocyte development (GO:0048821) | 5.90744836 |
| 12 | regulation of platelet activation (GO:0010543) | 5.62921851 |
| 13 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.45163068 |
| 14 | positive regulation of mast cell activation (GO:0033005) | 5.18824397 |
| 15 | erythrocyte differentiation (GO:0030218) | 5.07347263 |
| 16 | response to lead ion (GO:0010288) | 4.98127721 |
| 17 | response to insecticide (GO:0017085) | 4.97374454 |
| 18 | adenosine receptor signaling pathway (GO:0001973) | 4.96075544 |
| 19 | myeloid cell development (GO:0061515) | 4.95517888 |
| 20 | negative regulation of norepinephrine secretion (GO:0010700) | 4.92660661 |
| 21 | pigment biosynthetic process (GO:0046148) | 4.89557688 |
| 22 | megakaryocyte development (GO:0035855) | 4.68473155 |
| 23 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.67250525 |
| 24 | neutrophil activation (GO:0042119) | 4.67201070 |
| 25 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.63631331 |
| 26 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.46719374 |
| 27 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.46452782 |
| 28 | negative regulation of platelet activation (GO:0010544) | 4.32011951 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.29802099 |
| 30 | negative regulation of viral entry into host cell (GO:0046597) | 4.26557608 |
| 31 | regulation of lipoprotein metabolic process (GO:0050746) | 4.22496309 |
| 32 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.20862387 |
| 33 | pigment metabolic process (GO:0042440) | 4.19237152 |
| 34 | plasma lipoprotein particle assembly (GO:0034377) | 4.15559468 |
| 35 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.13148526 |
| 36 | granulocyte activation (GO:0036230) | 4.12099771 |
| 37 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.09742233 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.09575468 |
| 39 | granulocyte differentiation (GO:0030851) | 4.08642122 |
| 40 | platelet degranulation (GO:0002576) | 4.02286040 |
| 41 | embryonic hemopoiesis (GO:0035162) | 4.00879912 |
| 42 | regulation of integrin activation (GO:0033623) | 3.99154824 |
| 43 | lipoxygenase pathway (GO:0019372) | 3.93861750 |
| 44 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.92811497 |
| 45 | homotypic cell-cell adhesion (GO:0034109) | 3.90658248 |
| 46 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.88916437 |
| 47 | platelet formation (GO:0030220) | 3.84081652 |
| 48 | definitive hemopoiesis (GO:0060216) | 3.77100843 |
| 49 | purine-containing compound salvage (GO:0043101) | 3.76108954 |
| 50 | response to arsenic-containing substance (GO:0046685) | 3.75461643 |
| 51 | positive regulation of macrophage differentiation (GO:0045651) | 3.75007100 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.72748332 |
| 53 | protein-lipid complex assembly (GO:0065005) | 3.72376669 |
| 54 | platelet activation (GO:0030168) | 3.70642978 |
| 55 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.65046198 |
| 56 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.65046198 |
| 57 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.64180623 |
| 58 | positive regulation of receptor recycling (GO:0001921) | 3.54201025 |
| 59 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.54136231 |
| 60 | negative regulation of heart rate (GO:0010459) | 3.49987916 |
| 61 | heme transport (GO:0015886) | 3.48401466 |
| 62 | regulation of mast cell activation (GO:0033003) | 3.48152412 |
| 63 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.45897811 |
| 64 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.45216704 |
| 65 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.44111521 |
| 66 | positive regulation of coagulation (GO:0050820) | 3.41282289 |
| 67 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.37495252 |
| 68 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.35412994 |
| 69 | positive regulation of granulocyte differentiation (GO:0030854) | 3.33326124 |
| 70 | regulation of regulatory T cell differentiation (GO:0045589) | 3.31447314 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 3.29576622 |
| 72 | leukocyte degranulation (GO:0043299) | 3.28815693 |
| 73 | purinergic receptor signaling pathway (GO:0035587) | 3.28652076 |
| 74 | receptor recycling (GO:0001881) | 3.26262558 |
| 75 | regulation of erythrocyte differentiation (GO:0045646) | 3.25829555 |
| 76 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.23483289 |
| 77 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.22589845 |
| 78 | microglial cell activation (GO:0001774) | 3.19920235 |
| 79 | regulation of mast cell degranulation (GO:0043304) | 3.19876596 |
| 80 | cofactor biosynthetic process (GO:0051188) | 3.18439923 |
| 81 | iron ion import (GO:0097286) | 3.17346290 |
| 82 | negative regulation of monooxygenase activity (GO:0032769) | 3.13449460 |
| 83 | polyamine biosynthetic process (GO:0006596) | 3.13342521 |
| 84 | regulation of viral entry into host cell (GO:0046596) | 3.10475354 |
| 85 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.10210395 |
| 86 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.09215574 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.09215574 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 3.08578717 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.08578717 |
| 90 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.08010665 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 3.06709345 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06186091 |
| 93 | negative regulation of protein localization to cell surface (GO:2000009) | 3.06123883 |
| 94 | actin filament capping (GO:0051693) | 3.05889541 |
| 95 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.05832895 |
| 96 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.05727985 |
| 97 | negative regulation of heart contraction (GO:0045822) | 3.03927117 |
| 98 | negative regulation of T cell apoptotic process (GO:0070233) | 3.03727562 |
| 99 | termination of signal transduction (GO:0023021) | 3.03697572 |
| 100 | negative regulation of response to food (GO:0032096) | 3.01487877 |
| 101 | negative regulation of appetite (GO:0032099) | 3.01487877 |
| 102 | mesodermal cell differentiation (GO:0048333) | 3.01039559 |
| 103 | autophagic vacuole fusion (GO:0000046) | 3.00981981 |
| 104 | ovulation from ovarian follicle (GO:0001542) | 3.00067621 |
| 105 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.99919513 |
| 106 | negative regulation of catecholamine secretion (GO:0033604) | 2.98588585 |
| 107 | regulation of memory T cell differentiation (GO:0043380) | 2.98138905 |
| 108 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.97366168 |
| 109 | dendritic cell chemotaxis (GO:0002407) | 2.96510110 |
| 110 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.95870467 |
| 111 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95598804 |
| 112 | N-acetylneuraminate metabolic process (GO:0006054) | 2.95037252 |
| 113 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.94840598 |
| 114 | negative regulation of interleukin-17 production (GO:0032700) | 2.94131945 |
| 115 | phagocytosis, engulfment (GO:0006911) | 2.93828762 |
| 116 | negative regulation of bone mineralization (GO:0030502) | 2.93778263 |
| 117 | regulation of endothelial cell differentiation (GO:0045601) | 2.92111017 |
| 118 | regulation of blood coagulation (GO:0030193) | 2.91153843 |
| 119 | regulation of hemostasis (GO:1900046) | 2.91153843 |
| 120 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.87388567 |
| 121 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.85717996 |
| 122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.82261392 |
| 123 | negative regulation of cell killing (GO:0031342) | 2.82261392 |
| 124 | cellular extravasation (GO:0045123) | 2.81531856 |
| 125 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79705618 |
| 126 | negative regulation of stress fiber assembly (GO:0051497) | 2.79620507 |
| 127 | regulation of response to osmotic stress (GO:0047484) | 2.78789428 |
| 128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.76408134 |
| 129 | plasma lipoprotein particle organization (GO:0071827) | 2.75658227 |
| 130 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.75216776 |
| 131 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.73524824 |
| 132 | mitochondrial calcium ion transport (GO:0006851) | 2.72002690 |
| 133 | positive regulation of isotype switching (GO:0045830) | 2.71810732 |
| 134 | hepatocyte apoptotic process (GO:0097284) | 2.71709870 |
| 135 | bicarbonate transport (GO:0015701) | 2.71362491 |
| 136 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70916560 |
| 137 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.70060830 |
| 138 | response to thyroid hormone (GO:0097066) | 2.69581011 |
| 139 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.68372855 |
| 140 | blood coagulation, intrinsic pathway (GO:0007597) | 2.68369763 |
| 141 | regulation of female receptivity (GO:0045924) | 2.67505558 |
| 142 | hemopoiesis (GO:0030097) | 2.65586792 |
| 143 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.64229797 |
| 144 | positive regulation of B cell differentiation (GO:0045579) | 2.63314028 |
| 145 | protein-lipid complex subunit organization (GO:0071825) | 2.59610231 |
| 146 | hydrogen peroxide catabolic process (GO:0042744) | 2.59417773 |
| 147 | protein-cofactor linkage (GO:0018065) | 2.58374781 |
| 148 | positive regulation of histone deacetylation (GO:0031065) | 2.58340831 |
| 149 | cellular response to dexamethasone stimulus (GO:0071549) | 2.57018380 |
| 150 | cysteine metabolic process (GO:0006534) | 2.55660467 |
| 151 | one-carbon compound transport (GO:0019755) | 2.50592462 |
| 152 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.49727105 |
| 153 | negative regulation of fibrinolysis (GO:0051918) | 2.49611190 |
| 154 | negative regulation of biomineral tissue development (GO:0070168) | 2.47076245 |
| 155 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.46148342 |
| 156 | response to dexamethasone (GO:0071548) | 2.45660483 |
| 157 | activation of MAPKKK activity (GO:0000185) | 2.45290836 |
| 158 | regulation of norepinephrine secretion (GO:0014061) | 2.42220307 |
| 159 | immunoglobulin mediated immune response (GO:0016064) | 2.39636172 |
| 160 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.37794778 |
| 161 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.37794778 |
| 162 | negative regulation of actin filament depolymerization (GO:0030835) | 2.36665653 |
| 163 | angiogenesis involved in wound healing (GO:0060055) | 2.34389217 |
| 164 | gas transport (GO:0015669) | 2.32494255 |
| 165 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.31573231 |
| 166 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.29555583 |
| 167 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.27815490 |
| 168 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.27605791 |
| 169 | phospholipid efflux (GO:0033700) | 2.27084247 |
| 170 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.27024814 |
| 171 | iron ion homeostasis (GO:0055072) | 2.26703240 |
| 172 | histone H3-K36 demethylation (GO:0070544) | 2.22308959 |
| 173 | Golgi transport vesicle coating (GO:0048200) | 2.21801116 |
| 174 | COPI coating of Golgi vesicle (GO:0048205) | 2.21801116 |
| 175 | protein autoprocessing (GO:0016540) | 2.19014049 |
| 176 | platelet aggregation (GO:0070527) | 2.18911319 |
| 177 | import into cell (GO:0098657) | 2.16323962 |
| 178 | maternal placenta development (GO:0001893) | 2.16081372 |
| 179 | adrenergic receptor signaling pathway (GO:0071875) | 2.15543005 |
| 180 | lipopolysaccharide metabolic process (GO:0008653) | 2.13548635 |
| 181 | purine nucleotide salvage (GO:0032261) | 2.13291173 |
| 182 | positive regulation of blood coagulation (GO:0030194) | 2.12272461 |
| 183 | positive regulation of hemostasis (GO:1900048) | 2.12272461 |
| 184 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.09691844 |
| 185 | protoporphyrinogen IX metabolic process (GO:0046501) | 18.0340418 |
| 186 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 16.9949842 |
| 187 | porphyrin-containing compound biosynthetic process (GO:0006779) | 11.6048169 |
| 188 | heme biosynthetic process (GO:0006783) | 11.2706479 |
| 189 | tetrapyrrole biosynthetic process (GO:0033014) | 10.2491046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.00919254 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.89178225 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.82244980 |
| 4 | * GATA1_19941826_ChIP-Seq_K562_Human | 4.20602752 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.03172860 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.93050204 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.83976853 |
| 8 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.69484807 |
| 9 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.37939065 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.07057197 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.97871135 |
| 12 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.70520469 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.69183640 |
| 14 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.64075503 |
| 15 | * GATA2_19941826_ChIP-Seq_K562_Human | 2.57234608 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.52342104 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13747806 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12114811 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02139066 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.00960301 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.00698942 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.00270393 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00023775 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96984770 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95974526 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88256355 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84009098 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82135775 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.80154788 |
| 30 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.79626199 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78603293 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71216946 |
| 33 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67412754 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.66183416 |
| 35 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.65365218 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64296079 |
| 37 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64035643 |
| 38 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.63670305 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62268895 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61666769 |
| 41 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.60627340 |
| 42 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59590770 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54594470 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53405372 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52588013 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52245388 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51280159 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50632156 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.50300885 |
| 50 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.47595281 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42903194 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42891333 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42777819 |
| 54 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.42690853 |
| 55 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.41218028 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41155232 |
| 57 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.40887238 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40561980 |
| 59 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.40405643 |
| 60 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.39239787 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38252433 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38124618 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37611815 |
| 64 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36873724 |
| 65 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36670737 |
| 66 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32525574 |
| 67 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.31668694 |
| 68 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.30196827 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29241330 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.29021625 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.28964484 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28808326 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.28627276 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27976377 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.27230645 |
| 76 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27031795 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26600568 |
| 78 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26502968 |
| 79 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25473891 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24767609 |
| 81 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23744791 |
| 82 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.21698459 |
| 83 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19002229 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18888502 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17645023 |
| 86 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16497529 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16303162 |
| 88 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.13835509 |
| 89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13050980 |
| 90 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.12014810 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11938951 |
| 92 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11861519 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11667075 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10651764 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09604206 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08413695 |
| 97 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07862686 |
| 98 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07467217 |
| 99 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.07446989 |
| 100 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07285566 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06291932 |
| 102 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.05746840 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05027713 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05027713 |
| 105 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04527539 |
| 106 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03190460 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.02034612 |
| 108 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.01980471 |
| 109 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.01890881 |
| 110 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01732372 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.01393641 |
| 112 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99987020 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.97942617 |
| 114 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.96205122 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.96057654 |
| 116 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95310392 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95047450 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94579383 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.93164082 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 0.92877351 |
| 121 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92432595 |
| 122 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91850141 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91828214 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91603971 |
| 125 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91115722 |
| 126 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.90949308 |
| 127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.90258749 |
| 128 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.90068918 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88644252 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.88478621 |
| 131 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88051826 |
| 132 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.87314306 |
| 133 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.86560815 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86356571 |
| 135 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84950789 |
| 136 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.84692030 |
| 137 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.84404814 |
| 138 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83847154 |
| 139 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83796672 |
| 140 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.83685963 |
| 141 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82377516 |
| 142 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81911539 |
| 143 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80465835 |
| 144 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77256972 |
| 145 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75000850 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74964288 |
| 147 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74639439 |
| 148 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.74601847 |
| 149 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.74494443 |
| 150 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.74437027 |
| 151 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.71945541 |
| 152 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71776913 |
| 153 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71734459 |
| 154 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71547359 |
| 155 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.71316546 |
| 156 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.70762807 |
| 157 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.70098662 |
| 158 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.69390565 |
| 159 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.68565433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 9.06441825 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 8.97285180 |
| 3 | MP0008004_abnormal_stomach_pH | 5.34891690 |
| 4 | MP0005083_abnormal_biliary_tract | 2.79292481 |
| 5 | MP0000685_abnormal_immune_system | 2.26212984 |
| 6 | * MP0005464_abnormal_platelet_physiology | 2.24422940 |
| 7 | MP0006054_spinal_hemorrhage | 2.24292939 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.22140596 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.15667015 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.13122718 |
| 11 | MP0003828_pulmonary_edema | 2.05301587 |
| 12 | MP0001545_abnormal_hematopoietic_system | 1.97357840 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 1.97357840 |
| 14 | MP0005636_abnormal_mineral_homeostasis | 1.95110181 |
| 15 | MP0003111_abnormal_nucleus_morphology | 1.83268430 |
| 16 | MP0010368_abnormal_lymphatic_system | 1.81265749 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 1.76284142 |
| 18 | MP0001851_eye_inflammation | 1.74888807 |
| 19 | MP0000230_abnormal_systemic_arterial | 1.72016407 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 1.70541159 |
| 21 | MP0005671_abnormal_response_to | 1.70409393 |
| 22 | MP0004510_myositis | 1.65105896 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.61200811 |
| 24 | MP0002736_abnormal_nociception_after | 1.59769560 |
| 25 | MP0004130_abnormal_muscle_cell | 1.58744012 |
| 26 | * MP0002398_abnormal_bone_marrow | 1.53778720 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.53425659 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.52484520 |
| 29 | MP0003638_abnormal_response/metabolism_ | 1.51946062 |
| 30 | MP0004036_abnormal_muscle_relaxation | 1.51020963 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.47769678 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.47709109 |
| 33 | MP0000689_abnormal_spleen_morphology | 1.46548910 |
| 34 | MP0002722_abnormal_immune_system | 1.43873730 |
| 35 | MP0003303_peritoneal_inflammation | 1.43498443 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.41714073 |
| 37 | MP0000858_altered_metastatic_potential | 1.38193004 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.37897916 |
| 39 | MP0002132_abnormal_respiratory_system | 1.37640244 |
| 40 | MP0000249_abnormal_blood_vessel | 1.36932007 |
| 41 | MP0009785_altered_susceptibility_to | 1.34680090 |
| 42 | MP0001663_abnormal_digestive_system | 1.31316855 |
| 43 | MP0003436_decreased_susceptibility_to | 1.30152307 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.28337775 |
| 45 | * MP0002429_abnormal_blood_cell | 1.26333619 |
| 46 | MP0009765_abnormal_xenobiotic_induced | 1.25624360 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.24697785 |
| 48 | MP0005310_abnormal_salivary_gland | 1.20410455 |
| 49 | MP0005025_abnormal_response_to | 1.20384983 |
| 50 | MP0000609_abnormal_liver_physiology | 1.18394372 |
| 51 | MP0003186_abnormal_redox_activity | 1.16342415 |
| 52 | MP0005409_darkened_coat_color | 1.12875603 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.12365957 |
| 54 | MP0004883_abnormal_blood_vessel | 1.09871083 |
| 55 | MP0001790_abnormal_immune_system | 1.09364445 |
| 56 | MP0005387_immune_system_phenotype | 1.09364445 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.09350886 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.09314634 |
| 59 | MP0003879_abnormal_hair_cell | 1.08903756 |
| 60 | MP0005085_abnormal_gallbladder_physiolo | 1.08757641 |
| 61 | MP0003195_calcinosis | 1.07191778 |
| 62 | MP0000490_abnormal_crypts_of | 1.06856094 |
| 63 | MP0009763_increased_sensitivity_to | 1.06678802 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.06310100 |
| 65 | MP0002419_abnormal_innate_immunity | 1.04658534 |
| 66 | MP0004484_altered_response_of | 1.04224414 |
| 67 | MP0009333_abnormal_splenocyte_physiolog | 1.03856112 |
| 68 | MP0005410_abnormal_fertilization | 1.03758876 |
| 69 | MP0003724_increased_susceptibility_to | 1.03126943 |
| 70 | MP0008260_abnormal_autophagy | 1.01428643 |
| 71 | MP0000598_abnormal_liver_morphology | 1.00264529 |
| 72 | MP0009697_abnormal_copulation | 1.00087987 |
| 73 | MP0008874_decreased_physiological_sensi | 0.98492077 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.98262928 |
| 75 | MP0003077_abnormal_cell_cycle | 0.97926765 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.97899911 |
| 77 | MP0001879_abnormal_lymphatic_vessel | 0.97862694 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.97734452 |
| 79 | MP0009931_abnormal_skin_appearance | 0.96488013 |
| 80 | MP0003866_abnormal_defecation | 0.95988394 |
| 81 | MP0001800_abnormal_humoral_immune | 0.95950348 |
| 82 | MP0009840_abnormal_foam_cell | 0.94751423 |
| 83 | MP0002452_abnormal_antigen_presenting | 0.94402582 |
| 84 | MP0008469_abnormal_protein_level | 0.94176290 |
| 85 | MP0002420_abnormal_adaptive_immunity | 0.92904859 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.92593820 |
| 87 | MP0008775_abnormal_heart_ventricle | 0.92459250 |
| 88 | MP0001968_abnormal_touch/_nociception | 0.92026616 |
| 89 | MP0004947_skin_inflammation | 0.91280702 |
| 90 | MP0001819_abnormal_immune_cell | 0.90901781 |
| 91 | MP0000716_abnormal_immune_system | 0.90860540 |
| 92 | MP0002405_respiratory_system_inflammati | 0.89000746 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.88982725 |
| 94 | MP0002723_abnormal_immune_serum | 0.88891689 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.88585492 |
| 96 | MP0005023_abnormal_wound_healing | 0.87896188 |
| 97 | MP0005058_abnormal_lysosome_morphology | 0.87611980 |
| 98 | MP0000343_altered_response_to | 0.86073326 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.85399025 |
| 100 | MP0008872_abnormal_physiological_respon | 0.85288208 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.83163636 |
| 102 | MP0003091_abnormal_cell_migration | 0.83066572 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.82159826 |
| 104 | * MP0009642_abnormal_blood_homeostasis | 0.81837545 |
| 105 | MP0004381_abnormal_hair_follicle | 0.79736294 |
| 106 | MP0005360_urolithiasis | 0.79528427 |
| 107 | MP0003448_altered_tumor_morphology | 0.79437961 |
| 108 | MP0003172_abnormal_lysosome_physiology | 0.78958840 |
| 109 | MP0000313_abnormal_cell_death | 0.78685781 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.78666335 |
| 111 | MP0010094_abnormal_chromosome_stability | 0.78559952 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.77392817 |
| 113 | MP0003693_abnormal_embryo_hatching | 0.76751826 |
| 114 | MP0009764_decreased_sensitivity_to | 0.76741825 |
| 115 | MP0000703_abnormal_thymus_morphology | 0.75604103 |
| 116 | MP0003453_abnormal_keratinocyte_physiol | 0.75526281 |
| 117 | MP0005165_increased_susceptibility_to | 0.74749173 |
| 118 | MP0010307_abnormal_tumor_latency | 0.74163922 |
| 119 | MP0005646_abnormal_pituitary_gland | 0.74116262 |
| 120 | MP0001873_stomach_inflammation | 0.73876163 |
| 121 | MP0001853_heart_inflammation | 0.73564746 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.72858625 |
| 123 | MP0005365_abnormal_bile_salt | 0.72382381 |
| 124 | MP0005319_abnormal_enzyme/_coenzyme | 0.71523026 |
| 125 | MP0001764_abnormal_homeostasis | 0.69921143 |
| 126 | MP0002972_abnormal_cardiac_muscle | 0.69698161 |
| 127 | MP0001664_abnormal_digestion | 0.69555276 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.68732047 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.68732047 |
| 130 | MP0002332_abnormal_exercise_endurance | 0.67770031 |
| 131 | MP0003806_abnormal_nucleotide_metabolis | 0.67642100 |
| 132 | MP0008770_decreased_survivor_rate | 0.67484825 |
| 133 | MP0003252_abnormal_bile_duct | 0.66952730 |
| 134 | MP0002078_abnormal_glucose_homeostasis | 0.66590820 |
| 135 | MP0000749_muscle_degeneration | 0.65259196 |
| 136 | MP0004957_abnormal_blastocyst_morpholog | 0.65168030 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.65083401 |
| 138 | MP0003763_abnormal_thymus_physiology | 0.64751871 |
| 139 | MP0002128_abnormal_blood_circulation | 0.64308642 |
| 140 | MP0002019_abnormal_tumor_incidence | 0.64077395 |
| 141 | MP0005535_abnormal_body_temperature | 0.63964606 |
| 142 | MP0005501_abnormal_skin_physiology | 0.63175304 |
| 143 | MP0003075_altered_response_to | 0.62559817 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.61176182 |
| 145 | MP0003123_paternal_imprinting | 0.60827873 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.60182746 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 8.68697696 |
| 2 | Acanthocytosis (HP:0001927) | 8.40745605 |
| 3 | Reticulocytosis (HP:0001923) | 6.96409292 |
| 4 | Cholelithiasis (HP:0001081) | 5.75291396 |
| 5 | Polycythemia (HP:0001901) | 5.35601105 |
| 6 | Abnormal gallbladder morphology (HP:0012437) | 5.34204527 |
| 7 | Paralysis (HP:0003470) | 5.26300755 |
| 8 | Diaphragmatic weakness (HP:0009113) | 5.11921688 |
| 9 | Hyperbilirubinemia (HP:0002904) | 4.96351478 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.91300605 |
| 11 | Microcytic anemia (HP:0001935) | 4.78737698 |
| 12 | Osteomalacia (HP:0002749) | 4.70673243 |
| 13 | Abnormality of reticulocytes (HP:0004312) | 4.54754275 |
| 14 | Hypochromic anemia (HP:0001931) | 4.47290186 |
| 15 | Insomnia (HP:0100785) | 4.21456713 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 4.16406831 |
| 17 | Cholecystitis (HP:0001082) | 4.16406831 |
| 18 | Prolonged bleeding time (HP:0003010) | 4.01100146 |
| 19 | Petechiae (HP:0000967) | 3.79786783 |
| 20 | Abnormality of the gallbladder (HP:0005264) | 3.71058558 |
| 21 | Bruising susceptibility (HP:0000978) | 3.59169710 |
| 22 | Dyschromatopsia (HP:0007641) | 3.57952489 |
| 23 | Nonimmune hydrops fetalis (HP:0001790) | 3.54042323 |
| 24 | Epistaxis (HP:0000421) | 3.44802135 |
| 25 | Abnormal platelet function (HP:0011869) | 3.36395732 |
| 26 | Impaired platelet aggregation (HP:0003540) | 3.36395732 |
| 27 | Cutaneous photosensitivity (HP:0000992) | 3.16575080 |
| 28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.13134615 |
| 29 | Purpura (HP:0000979) | 3.11368923 |
| 30 | Amaurosis fugax (HP:0100576) | 3.08321223 |
| 31 | Menorrhagia (HP:0000132) | 3.07319925 |
| 32 | Abnormal pupillary function (HP:0007686) | 3.05863640 |
| 33 | Ileus (HP:0002595) | 3.03776672 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.01931101 |
| 35 | Hepatocellular carcinoma (HP:0001402) | 3.01687556 |
| 36 | Increased density of long bones (HP:0006392) | 2.95612814 |
| 37 | Stomatitis (HP:0010280) | 2.82397464 |
| 38 | Nausea (HP:0002018) | 2.81897992 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.73386822 |
| 40 | Abnormality of iron homeostasis (HP:0011031) | 2.70312423 |
| 41 | Increased serum ferritin (HP:0003281) | 2.69612434 |
| 42 | Urticaria (HP:0001025) | 2.68948107 |
| 43 | Eczematoid dermatitis (HP:0000976) | 2.57424610 |
| 44 | Cerebral palsy (HP:0100021) | 2.53280900 |
| 45 | Arterial thrombosis (HP:0004420) | 2.51117649 |
| 46 | Gingival bleeding (HP:0000225) | 2.47481060 |
| 47 | Joint swelling (HP:0001386) | 2.41547058 |
| 48 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.40051753 |
| 49 | Abnormality of lateral ventricle (HP:0030047) | 2.38998754 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.32866050 |
| 51 | Abnormal platelet volume (HP:0011876) | 2.32609339 |
| 52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31717232 |
| 53 | Obstructive lung disease (HP:0006536) | 2.31717232 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.31064761 |
| 55 | Generalized hyperpigmentation (HP:0007440) | 2.29085955 |
| 56 | Encephalitis (HP:0002383) | 2.28695244 |
| 57 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.27431357 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 2.27312155 |
| 59 | Increased mean platelet volume (HP:0011877) | 2.26374704 |
| 60 | Tinnitus (HP:0000360) | 2.25907514 |
| 61 | Increased IgM level (HP:0003496) | 2.25480796 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.25095080 |
| 63 | Autoimmune thrombocytopenia (HP:0001973) | 2.17701611 |
| 64 | Joint hemorrhage (HP:0005261) | 2.14571396 |
| 65 | Hyponatremia (HP:0002902) | 2.14456274 |
| 66 | Papillary thyroid carcinoma (HP:0002895) | 2.14217179 |
| 67 | Thrombophlebitis (HP:0004418) | 2.11798694 |
| 68 | Chest pain (HP:0100749) | 2.09172776 |
| 69 | Episodic fever (HP:0001954) | 2.06338693 |
| 70 | Hypoglycemic seizures (HP:0002173) | 2.05064201 |
| 71 | Tetraparesis (HP:0002273) | 2.04040561 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03410042 |
| 73 | Upper limb muscle weakness (HP:0003484) | 2.02464444 |
| 74 | Abnormal number of erythroid precursors (HP:0012131) | 2.02081282 |
| 75 | Vertebral compression fractures (HP:0002953) | 2.01013582 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.00449930 |
| 77 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 12.6593769 |
| 78 | Poikilocytosis (HP:0004447) | 10.3108752 |
| 79 | Autoimmune hemolytic anemia (HP:0001890) | 1.97763362 |
| 80 | Decreased central vision (HP:0007663) | 1.96252322 |
| 81 | Hypoglycemic coma (HP:0001325) | 1.95648955 |
| 82 | Pathologic fracture (HP:0002756) | 1.93308591 |
| 83 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.93081878 |
| 84 | Hypertensive crisis (HP:0100735) | 1.91887053 |
| 85 | Short middle phalanx of the 5th finger (HP:0004220) | 1.90524877 |
| 86 | Broad palm (HP:0001169) | 1.87946840 |
| 87 | Aplastic anemia (HP:0001915) | 1.87730827 |
| 88 | Myocardial infarction (HP:0001658) | 1.83562093 |
| 89 | Vertigo (HP:0002321) | 1.82146429 |
| 90 | Depression (HP:0000716) | 1.78033608 |
| 91 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77278839 |
| 92 | Thrombocytosis (HP:0001894) | 1.76575657 |
| 93 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76068715 |
| 94 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76068715 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 1.75879360 |
| 96 | Macrocytic anemia (HP:0001972) | 1.75438472 |
| 97 | Abnormality of sodium homeostasis (HP:0010931) | 1.74658246 |
| 98 | Recurrent abscess formation (HP:0002722) | 1.74644525 |
| 99 | Nasal polyposis (HP:0100582) | 1.74332527 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.74073807 |
| 101 | Lower limb hyperreflexia (HP:0002395) | 1.74021003 |
| 102 | Abnormality of B cell number (HP:0010975) | 1.73912473 |
| 103 | B lymphocytopenia (HP:0010976) | 1.73912473 |
| 104 | Leukocytosis (HP:0001974) | 1.73678119 |
| 105 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.72756809 |
| 106 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.72130861 |
| 107 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.69559831 |
| 108 | T lymphocytopenia (HP:0005403) | 1.68483466 |
| 109 | Progressive microcephaly (HP:0000253) | 1.68472937 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 1.68437118 |
| 111 | Ventricular fibrillation (HP:0001663) | 1.68398152 |
| 112 | Inflammation of the large intestine (HP:0002037) | 1.65950481 |
| 113 | Hyperthyroidism (HP:0000836) | 1.64389555 |
| 114 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.62670303 |
| 115 | Hematochezia (HP:0002573) | 1.62378884 |
| 116 | Optic neuritis (HP:0100653) | 1.62213521 |
| 117 | Retrobulbar optic neuritis (HP:0100654) | 1.62213521 |
| 118 | Muscle fibrillation (HP:0010546) | 1.62207723 |
| 119 | Leiomyosarcoma (HP:0100243) | 1.62051233 |
| 120 | Uterine leiomyosarcoma (HP:0002891) | 1.62051233 |
| 121 | Testicular neoplasm (HP:0010788) | 1.60732087 |
| 122 | Conjunctival telangiectasia (HP:0000524) | 1.59516095 |
| 123 | Basal ganglia calcification (HP:0002135) | 1.59279763 |
| 124 | Abnormality of T cell number (HP:0011839) | 1.58620368 |
| 125 | Anorexia (HP:0002039) | 1.58037583 |
| 126 | Diplopia (HP:0000651) | 1.57825684 |
| 127 | Abnormality of binocular vision (HP:0011514) | 1.57825684 |
| 128 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57652080 |
| 129 | Male infertility (HP:0003251) | 1.57463374 |
| 130 | Renal tubular acidosis (HP:0001947) | 1.57086803 |
| 131 | Onycholysis (HP:0001806) | 1.54770893 |
| 132 | Vasculitis (HP:0002633) | 1.54595857 |
| 133 | Xanthomatosis (HP:0000991) | 1.52246281 |
| 134 | Confusion (HP:0001289) | 1.52146649 |
| 135 | Myositis (HP:0100614) | 1.52013071 |
| 136 | Distal lower limb amyotrophy (HP:0008944) | 1.51866287 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.51244919 |
| 138 | Bladder carcinoma (HP:0002862) | 1.50886638 |
| 139 | Bladder neoplasm (HP:0009725) | 1.50886638 |
| 140 | Tongue fasciculations (HP:0001308) | 1.50586911 |
| 141 | Gastrointestinal inflammation (HP:0004386) | 1.49431312 |
| 142 | Pustule (HP:0200039) | 1.49194402 |
| 143 | Dysostosis multiplex (HP:0000943) | 1.48688317 |
| 144 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.48638046 |
| 145 | Metabolic acidosis (HP:0001942) | 1.47726468 |
| 146 | Orchitis (HP:0100796) | 1.47062153 |
| 147 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.46956353 |
| 148 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.46785011 |
| 149 | Abnormality of the prostate (HP:0008775) | 1.46609278 |
| 150 | Dysautonomia (HP:0002459) | 1.46182741 |
| 151 | Symptomatic seizures (HP:0011145) | 1.46053640 |
| 152 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.45927367 |
| 153 | Spontaneous abortion (HP:0005268) | 1.45806973 |
| 154 | Recurrent fungal infections (HP:0002841) | 1.44485803 |
| 155 | Gastrointestinal infarctions (HP:0005244) | 1.43087610 |
| 156 | Mucosal telangiectasiae (HP:0100579) | 1.43024515 |
| 157 | Cerebral ischemia (HP:0002637) | 1.41964562 |
| 158 | Neoplasm of the liver (HP:0002896) | 1.41582949 |
| 159 | IgM deficiency (HP:0002850) | 1.41478928 |
| 160 | Granulocytopenia (HP:0001913) | 1.41392421 |
| 161 | Hypertriglyceridemia (HP:0002155) | 1.41228576 |
| 162 | Thyroid-stimulating hormone excess (HP:0002925) | 1.40347371 |
| 163 | Global brain atrophy (HP:0002283) | 1.40319713 |
| 164 | Splenomegaly (HP:0001744) | 1.40278493 |
| 165 | Meningitis (HP:0001287) | 1.39966365 |
| 166 | Pulmonary embolism (HP:0002204) | 1.39668490 |
| 167 | Eosinophilia (HP:0001880) | 1.38376802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 6.33731939 |
| 2 | EIF2AK1 | 5.66454693 |
| 3 | MST4 | 3.83745974 |
| 4 | MYLK | 2.92122473 |
| 5 | KDR | 2.84395302 |
| 6 | TGFBR2 | 2.62445201 |
| 7 | TIE1 | 2.57043318 |
| 8 | MAP4K1 | 2.55843794 |
| 9 | BRSK2 | 2.54988365 |
| 10 | TRIB3 | 2.38964677 |
| 11 | PIK3CG | 2.34979653 |
| 12 | MAP3K10 | 2.31727497 |
| 13 | BRSK1 | 2.21346122 |
| 14 | BMPR2 | 2.07901162 |
| 15 | FGR | 2.04512880 |
| 16 | EEF2K | 2.02237764 |
| 17 | TAOK3 | 1.95655077 |
| 18 | GRK5 | 1.92393662 |
| 19 | STK10 | 1.91241381 |
| 20 | HCK | 1.77856267 |
| 21 | TBK1 | 1.74124002 |
| 22 | SYK | 1.68364448 |
| 23 | PIM1 | 1.67792045 |
| 24 | FES | 1.66209949 |
| 25 | STK4 | 1.65691145 |
| 26 | JAK3 | 1.63861496 |
| 27 | MAPKAPK3 | 1.57626270 |
| 28 | PKN2 | 1.55418655 |
| 29 | FLT3 | 1.44193328 |
| 30 | STK24 | 1.39376011 |
| 31 | TYK2 | 1.36377347 |
| 32 | EPHB1 | 1.34739004 |
| 33 | LRRK2 | 1.34418371 |
| 34 | IKBKE | 1.26566085 |
| 35 | JAK2 | 1.25295032 |
| 36 | CDK9 | 1.23252386 |
| 37 | TNK2 | 1.22241006 |
| 38 | BUB1 | 1.20498141 |
| 39 | ITK | 1.17274643 |
| 40 | HIPK2 | 1.16496514 |
| 41 | TRPM7 | 1.15979178 |
| 42 | ZAP70 | 1.13163326 |
| 43 | IRAK1 | 1.09914855 |
| 44 | GRK6 | 1.09618453 |
| 45 | CDC7 | 1.08349353 |
| 46 | MAPK11 | 1.07498842 |
| 47 | KIT | 1.07375460 |
| 48 | LYN | 1.05852564 |
| 49 | PTK6 | 1.05025595 |
| 50 | RPS6KA5 | 1.04536985 |
| 51 | IKBKB | 1.02292327 |
| 52 | SIK3 | 1.01137660 |
| 53 | ADRBK2 | 0.97918315 |
| 54 | ERN1 | 0.97422883 |
| 55 | PRKG2 | 0.97248779 |
| 56 | MAPKAPK5 | 0.94964588 |
| 57 | ACVR1B | 0.93821449 |
| 58 | FGFR4 | 0.93708911 |
| 59 | TNIK | 0.93375486 |
| 60 | PAK1 | 0.91673429 |
| 61 | CDK6 | 0.90936804 |
| 62 | YES1 | 0.89682928 |
| 63 | TLK1 | 0.89055735 |
| 64 | MAP3K5 | 0.88958437 |
| 65 | PLK2 | 0.87515014 |
| 66 | PINK1 | 0.86747598 |
| 67 | MARK3 | 0.86702509 |
| 68 | CDK12 | 0.85121013 |
| 69 | PNCK | 0.84984934 |
| 70 | JAK1 | 0.84906008 |
| 71 | NEK2 | 0.84866649 |
| 72 | CAMKK2 | 0.84847957 |
| 73 | MAP3K3 | 0.84656108 |
| 74 | MATK | 0.83649978 |
| 75 | VRK1 | 0.83339409 |
| 76 | MUSK | 0.83021091 |
| 77 | STK3 | 0.82823707 |
| 78 | BTK | 0.82132758 |
| 79 | MAP3K8 | 0.82090101 |
| 80 | CHUK | 0.82058216 |
| 81 | EPHA3 | 0.81453893 |
| 82 | IRAK4 | 0.80762214 |
| 83 | CHEK2 | 0.79649822 |
| 84 | LMTK2 | 0.79401492 |
| 85 | MAP2K3 | 0.77728101 |
| 86 | TXK | 0.77263008 |
| 87 | RPS6KB2 | 0.74954515 |
| 88 | TAOK2 | 0.71908913 |
| 89 | MAP3K11 | 0.71278041 |
| 90 | RPS6KA4 | 0.71140864 |
| 91 | NME2 | 0.70865750 |
| 92 | CLK1 | 0.70323519 |
| 93 | DYRK3 | 0.69872740 |
| 94 | MAPKAPK2 | 0.69717831 |
| 95 | ADRBK1 | 0.68842774 |
| 96 | IRAK2 | 0.67412675 |
| 97 | SGK2 | 0.67343849 |
| 98 | PASK | 0.63318996 |
| 99 | PDGFRB | 0.61103395 |
| 100 | PRKD1 | 0.60451601 |
| 101 | AURKB | 0.59461879 |
| 102 | MELK | 0.59353790 |
| 103 | MAPK12 | 0.57902686 |
| 104 | MAP2K2 | 0.57805682 |
| 105 | DAPK3 | 0.57787500 |
| 106 | SGK3 | 0.57436409 |
| 107 | AURKA | 0.55720465 |
| 108 | LCK | 0.55167336 |
| 109 | FYN | 0.54976673 |
| 110 | SCYL2 | 0.54853103 |
| 111 | CDK4 | 0.54167981 |
| 112 | NLK | 0.53298101 |
| 113 | TRIM28 | 0.53224404 |
| 114 | TEC | 0.52618805 |
| 115 | PRKACG | 0.51565482 |
| 116 | ALK | 0.51339639 |
| 117 | DYRK1B | 0.51124795 |
| 118 | PIM2 | 0.50971956 |
| 119 | ERBB2 | 0.49867583 |
| 120 | FER | 0.49672123 |
| 121 | PDK1 | 0.49516671 |
| 122 | BLK | 0.49511108 |
| 123 | MAP2K1 | 0.49462264 |
| 124 | DAPK1 | 0.48886525 |
| 125 | INSRR | 0.47648932 |
| 126 | PTK2B | 0.47309080 |
| 127 | MAPK15 | 0.47279743 |
| 128 | PDPK1 | 0.46793722 |
| 129 | BMX | 0.45613727 |
| 130 | CSF1R | 0.45185294 |
| 131 | DAPK2 | 0.44571083 |
| 132 | MAP3K1 | 0.43772471 |
| 133 | MAP3K7 | 0.42261160 |
| 134 | WEE1 | 0.42009680 |
| 135 | ILK | 0.40291835 |
| 136 | CDC42BPA | 0.39735394 |
| 137 | CSK | 0.39435119 |
| 138 | RET | 0.39343868 |
| 139 | PRKCQ | 0.38984251 |
| 140 | NEK9 | 0.38082016 |
| 141 | TAOK1 | 0.37692965 |
| 142 | PRKG1 | 0.34823256 |
| 143 | PAK3 | 0.34046860 |
| 144 | CAMK1G | 0.32754200 |
| 145 | PRKCD | 0.31343742 |
| 146 | IRAK3 | 0.31009159 |
| 147 | MAP3K2 | 0.29927616 |
| 148 | PKN1 | 0.27634934 |
| 149 | ARAF | 0.26188586 |
| 150 | PRKCB | 0.25930366 |
| 151 | TESK2 | 0.25727745 |
| 152 | RAF1 | 0.24533539 |
| 153 | MINK1 | 0.24356501 |
| 154 | SRC | 0.23083958 |
| 155 | MARK2 | 0.22781501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 8.66023138 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.63087437 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.32348641 |
| 4 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.17818258 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 2.51833011 |
| 6 | * Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.22234595 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.05490873 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.03148651 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.92059928 |
| 10 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.88568303 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.85383251 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79624133 |
| 13 | Alcoholism_Homo sapiens_hsa05034 | 1.67797114 |
| 14 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.66157149 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61301805 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53653019 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.52766283 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51296081 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50246840 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.45885580 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45438005 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.41580790 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37038918 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36581818 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.30261067 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.30077267 |
| 27 | Platelet activation_Homo sapiens_hsa04611 | 1.29622851 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.28520023 |
| 29 | Endocytosis_Homo sapiens_hsa04144 | 1.27906986 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24961818 |
| 31 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.23505563 |
| 32 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.21467320 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20639851 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17089526 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.14323489 |
| 36 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.13194243 |
| 37 | * Gap junction_Homo sapiens_hsa04540 | 1.07804842 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07394365 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07222953 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05955106 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.05827872 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.04681752 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.00768859 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 0.98409560 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.98340809 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 0.97916547 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97306273 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95097750 |
| 49 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.92848050 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91787325 |
| 51 | Measles_Homo sapiens_hsa05162 | 0.91552973 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91159024 |
| 53 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89542946 |
| 54 | Insulin resistance_Homo sapiens_hsa04931 | 0.89479383 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88886120 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.88662269 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88491916 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88324876 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 0.87965454 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.87935760 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87780130 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.87758028 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.87126947 |
| 64 | Bladder cancer_Homo sapiens_hsa05219 | 0.86691160 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85633427 |
| 66 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85196718 |
| 67 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84468952 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.82661992 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82092459 |
| 70 | Mismatch repair_Homo sapiens_hsa03430 | 0.82086729 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79402558 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78717229 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78510488 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.77890521 |
| 75 | * Phagosome_Homo sapiens_hsa04145 | 0.75996536 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74602700 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73986469 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73802294 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73741620 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70606927 |
| 81 | Olfactory transduction_Homo sapiens_hsa04740 | 0.69950271 |
| 82 | Allograft rejection_Homo sapiens_hsa05330 | 0.69249969 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.68896812 |
| 84 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67445435 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.67354589 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66302000 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65678398 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65155077 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.64971990 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64872844 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63902141 |
| 92 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63481026 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62654798 |
| 94 | Morphine addiction_Homo sapiens_hsa05032 | 0.62600966 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62283886 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61426781 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60650473 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.58925138 |
| 99 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58794691 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.57584911 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57436931 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56865039 |
| 103 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55964706 |
| 104 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54770159 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54004981 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53985159 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52814453 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.51529087 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51159969 |
| 110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50980140 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50728808 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.50600170 |
| 113 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49478209 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.49158277 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.48190190 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47654393 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.46796100 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.46526192 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46366522 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.46143604 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46143313 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45720797 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45447716 |
| 124 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45253775 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44247713 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.43993948 |
| 127 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43895293 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43495887 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43400442 |
| 130 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.43291178 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43231592 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.42602315 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42205270 |
| 134 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42091297 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41947128 |
| 136 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41004540 |
| 137 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40635181 |
| 138 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38764352 |
| 139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38267559 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37659424 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.36430348 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35196863 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34445089 |
| 144 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.33972080 |
| 145 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32879131 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32543848 |
| 147 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.32434646 |
| 148 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32303574 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32260971 |
| 150 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31144090 |
| 151 | Carbon metabolism_Homo sapiens_hsa01200 | 0.30543400 |
| 152 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29469250 |
| 153 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.27843273 |
| 154 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27265477 |
| 155 | Bile secretion_Homo sapiens_hsa04976 | 0.27251400 |
| 156 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27131035 |
| 157 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26627646 |
| 158 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.26254568 |
| 159 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25653187 |
| 160 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25461285 |
| 161 | Protein export_Homo sapiens_hsa03060 | 0.24659627 |
| 162 | Tuberculosis_Homo sapiens_hsa05152 | 0.24588455 |
| 163 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.24136200 |
| 164 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21972155 |

